Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones

被引：24
|
作者：
Brisse, S
Fluit, AC
Wagner, U
Heisig, P
Milatovic, D
Verhoef, J
Scheuring, S
Köhrer, K
Schmitz, FJ
机构：
[1] Univ Utrecht, Eijkman Winkler Inst, NL-3585 CX Utrecht, Netherlands
[2] Univ Hosp Dusseldorf, Inst Med Microbiol & virol, D-40225 Dusseldorf, Germany
[3] Univ Bonn, Inst Pharmaceut Microbiol, D-5300 Bonn, Germany
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1999年 / 43卷 / 10期
关键词：
D O I：
10.1128/AAC.43.10.2513
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The parC and gyrA genes of 73 ciprofloxacin-resistant and 6 ciprofloxacin-susceptible Enterococcus faecium clinical isolates were partly sequenced. Alterations in ParC and GyrA, possibly in combination with other resistance mechanisms, severely restricted the in vitro activities of the nine quinolones tested. For all isolates, clinafloxacin and sitafloxacin showed the best activities.
引用
收藏
页码：2513 / 2516
页数：4
相关论文
共 50 条
  • [21] Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis
    Bebear, CM
    Renaudin, J
    Charron, A
    Renaudin, H
    de Barbeyrac, B
    Schaeverbeke, T
    Bebear, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 954 - 956
  • [22] Relationship between mutations in parC and gyrA of clinical isolates of Streptococcus pneumoniae and resistance to ciprofloxacin and grepafloxacin
    Stewart, BA
    Johnson, AP
    Woodford, N
    JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (12) : 1103 - 1106
  • [23] Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci
    González, I
    Georgiou, M
    Alcaide, F
    Balas, D
    Liñares, J
    De la Campa, AG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2792 - 2798
  • [24] Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates
    Ostrer, Lev
    Khodursky, Rachel F.
    Johnson, James R.
    Hiasa, Hiroshi
    Khodursky, Arkady
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (03) : 318 - 324
  • [25] Sparfloxacin resistance in clinical isolates of Streptococcus pneumoniae:: Involvement of multiple mutations in gyrA and parC genes
    Taba, H
    Kusano, N
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2193 - 2196
  • [26] Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis
    Kanematsu, E
    Deguchi, T
    Yasuda, M
    Kawamura, T
    Nishino, Y
    Kawada, Y
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (02) : 433 - 435
  • [27] Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan
    Tanaka, M
    Takahashi, K
    Saika, T
    Kobayashi, I
    Ueno, T
    Kumazawa, J
    JOURNAL OF UROLOGY, 1998, 159 (06): : 2215 - 2219
  • [28] Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007
    Protonotariou, E.
    Dimitroulia, E.
    Pournaras, S.
    Pitiriga, V.
    Sofianou, D.
    Tsakris, A.
    JOURNAL OF HOSPITAL INFECTION, 2010, 75 (03) : 225 - 227
  • [29] Analysis of the prevalence of tetracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faecium in a Japanese hospital
    Nishimoto, Y
    Kobayashi, N
    Alam, MM
    Ishino, M
    Uehara, N
    Watanabe, N
    MICROBIAL DRUG RESISTANCE, 2005, 11 (02) : 146 - 153
  • [30] Drug resistance of Enterococcus faecium clinical isolates and the conjugative transfer of gentamicin and erythromycin resistance traits
    Takeuchi, K
    Tomita, H
    Fujimoto, S
    Kudo, M
    Kuwano, H
    Ike, Y
    FEMS MICROBIOLOGY LETTERS, 2005, 243 (02) : 347 - 354
12345